Why Finance With Brobas Capital Partners
App-only funding in two days
Colposcopes sit in easy app-only territory. One page, no financials, and money to the vendor in as little as two business days once you are approved.
Rates from 5.49% APR
Qualified gynecology practices start at 5.49% APR over 24 to 60 months. Pricing follows your credit and time in practice, so it is quoted firm once we see the file, not promised up front.
Optical and digital both covered
From a $9,800 Wallach ZoomStar to a $35,000 DYSIS mapping system, we fund the whole range on the same terms, new or refurbished.
Challenged credit welcome
Small-ticket medical lenders in our 500+ network underwrite the practice and the procedure economics, so a young office or a lower score still gets placed.
Colposcopy belongs in your office, not on a referral pad
The ASCCP guidelines are clear about who needs colposcopy, and if you manage women's health you already know the volume is steady: ASC-US with positive HPV, LSIL, HSIL, atypical glandular cells, persistent high-risk HPV. Sending those patients out does two things you do not want. It breaks continuity at the exact moment a patient is anxious, and it hands the reimbursement to another practice. A colposcope keeps the whole workup in-house. Under magnification with a green filter, you apply acetic acid, read the acetowhite epithelium and vascular patterns, apply Lugol's iodine where you want contrast, take directed biopsies, and perform an endocervical curettage when the guidelines call for it. The DYSIS system adds a pseudocolor map of acetowhitening over time, which is useful for documentation and for training. On the billing side you are capturing 57452 for the colposcopy, 57454 or 57455 when you biopsy, and 57460 or 57461 for a LEEP or conization done under colposcopic guidance. If you run pathology in-house, that revenue stays too. This is a low-cost machine that protects a high-value, high-frequency part of your practice.
Recent Funded Approvals
Colposcope deals we funded recently, anonymized:
- $31,500 DYSIS Medical colposcope for a solo OB-GYN in Atlanta, 11 years in practice, 721 credit score. Approved app-only at 5.99% APR over 48 months, zero down, funded in two business days.
- $14,200 Leisegang OptiK with video for a two-provider women's health office in Charlotte, 5 years in practice, 688 score. 6.49% APR over 36 months, 10% down.
- $9,800 Wallach ZoomStar for a startup gynecology practice in Nashville, 18 months in, 662 score (challenged credit). Funded at 6.99% APR over 36 months with 10% down.
- $22,000 Leisegang system with video capture and printer for a three-physician group in Savannah, 8 years in practice, 744 score. 5.49% APR over 48 months, zero down.
Revenue math and the Section 179 deduction
The economics here are lopsided in your favor. Take the Charlotte Leisegang at $14,200. Financed over 36 months at 6.49%, the payment lands around $435 a month. A single colposcopy with biopsy and ECC (57454) reimburses in the neighborhood of $250 to $350 depending on payer, so three or four procedures a month cover the note, and most practices doing regular Pap follow-up run more than that. Every colposcopy you would have referred out is now revenue that stays on your schedule, plus the office visit and any in-house pathology.
On taxes, a colposcope is a clean Section 179 candidate. Current rules let you expense the full purchase price in the year the equipment is placed in service, with a cap of $2.5 million that no single colposcope will ever approach, and 100% bonus depreciation applies to equipment placed in service in 2026. A $31,500 DYSIS system installed before December 31 can generally be deducted in full that tax year rather than spread across five. Your CPA will confirm how it lands on your return, but for a device this affordable, the after-tax cost of ownership is often a fraction of the sticker.
How app-only colposcope financing works
Because colposcopes sit at the low end of medical equipment pricing, nearly every one funds app-only. You send a single-page application, we run it, and that is the file. No tax returns, no profit-and-loss statement, no bank statements for most approvals. We take it to more than 500 lenders, including several who like small-ticket medical paper, and you typically have a decision the same day and money to the vendor inside two to three business days. That speed is the whole point when a distributor has a Leisegang or DYSIS unit ready to ship.
We fund new and refurbished colposcopes on identical terms and handle invoices from Wallach, Leisegang, DYSIS Medical, and their authorized distributors. Terms run 24 to 60 months, and we can defer the first payment while you install and train staff. Rates start from 5.49% APR for qualified practices and are priced off your credit profile, time in practice, and the equipment, so we quote firm once we see the file. A younger practice or a challenged credit history is not a wall here. Small-ticket lenders in our network underwrite the practice and the procedure economics, which is exactly why colposcopes are some of the easiest medical deals we place.
Frequently Asked Questions
How fast can a colposcope be funded?
For app-only deals, which is most colposcopes, you can have a same-day decision and funds to the vendor within two to three business days. We funded an Atlanta DYSIS system in two days start to finish.
Do I need to submit tax returns?
Usually no. Because colposcopes are small-ticket, most approvals are app-only with a single-page application and no tax returns, P&L, or bank statements required.
Can I finance a DYSIS Medical system?
Yes. We fund DYSIS digital mapping colposcopes as readily as optical Leisegang and Wallach units, new or refurbished, on the same terms.
What if my credit is not strong?
That is common for newer practices and it is not a blocker. With 500+ lenders, we place challenged credit files with underwriters who weigh the practice and the procedure economics, not just the score. Rates start from 5.49% APR for qualified offices.
Get Started Today
Apply online in 5 minutes or call (773) 900-7576. Soft credit look, no impact to apply. All credit profiles welcome, US medical providers only.